PA
RAIN

Parallel Advisors’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Parallel Advisors’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,250
Closed -$2.7K – 3461
2023
Q4 		$2.7K Hold
2,250
– – ﹤0.01% 2709
2023
Q3 		$1.94K Sell
2,250
-11,212
-83% -$12.3K ﹤0.01% 2829
2023
Q2 		$16.2K Buy
13,462
+1,000
+8% +$5K ﹤0.01% 1946
2023
Q1 		$109K Hold
12,462
– – ﹤0.01% 1018
2022
Q4 		$99.7K Hold
12,462
– – ﹤0.01% 986
2022
Q3 		$61K Hold
12,462
– – ﹤0.01% 1171
2022
Q2 		$69K Buy
12,462
+650
+6% +$2.23K ﹤0.01% 1111
2022
Q1 		$62K Buy
11,812
+300
+3% +$2.4K ﹤0.01% 1197
2021
Q4 		$148K Buy
11,512
+11,212
+3,737% +$160K 0.01% 862
2021
Q3 		$4K Buy
+300
New +$5.12K ﹤0.01% 2521

Parallel Advisors's RAIN Position: Q1 2024 in Review

Parallel Advisors sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 2,250 shares — an estimated $2.7K sold.

Parallel Advisors first reported a position in RAIN in Q3 2021 and held it in 10 quarters. The position peaked at $148K in Q4 2021. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

  • Parallel Advisors reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Parallel Advisors sold 2,250 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $2.7K.
  • Parallel Advisors first reported a position in Rain Oncology Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Parallel Advisors's Rain Oncology Inc. Common Stock position peaked at $148K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Parallel Advisors's 13F filing for Q1 2024, filed 6 May 2024.